Lack of efficacy of erlotinib in most EGFR mutated non-small cell lung cancers (NSCLCs) with acquired resistance to gefitinib Meeting Abstract


Authors: Costa, D. B.; Cho, B. C.; Sequist, L. V.; Riely, G. J.; Halmos, B.; Kim, J.; Huberman, M. S.; Pao, W.; Tenen, D. G.; Kobayashi, S.
Abstract Title: Lack of efficacy of erlotinib in most EGFR mutated non-small cell lung cancers (NSCLCs) with acquired resistance to gefitinib
Meeting Title: 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 26
Issue: 15 Suppl.
Meeting Dates: 2008 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2008-05-20
Start Page: 450s
Language: English
ACCESSION: WOS:000208457402903
DOI: 10.1200/jco.2008.26.15_suppl.8105
PROVIDER: wos
Notes: Meeting Abstract: 8105 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. William Pao
    141 Pao
  2. Gregory J Riely
    599 Riely